Researcher
An Vermeulen
- Keywords:Population analyses, Pediatrics, Pharmacometrics, Pharmacokinetics, Pharmacodynamics, PBPK
- Disciplines:Medicinal products, Pharmaceutics, Biomarker discovery and evaluation, Other pharmaceutical sciences, Drug discovery and development, Pharmacotherapy, Pharmacology, Clinical trials, Biopharmaceutics, Pharmacodynamics, Small molecules, Pharmacokinetics
Affiliations
- Department of Bio-analysis (Department)
Member
From1 Oct 2013 → Today
Projects
1 - 1 of 1
- Intraperitoneal Aerosolized Liposomal Irinotecan (NalIRI) in Peritoneal Carcinomatosis from GI cancer: a phase I firstinhuman studyFrom1 Aug 2021 → TodayFunding: Private funding of national origin - undefined
Publications
71 - 80 of 103
- Population pharmacokinetic analysis of abiraterone in chemotherapy-Na < ve and docetaxel-treated patients with metastatic castration-resistant prostate cancer(2014)
Authors: Kim Stuyckens, Fred Saad, Xu Steven Xu, Charles J Ryan, Matthew R Smith, Thomas W Griffin, Margaret K Yu, An Vermeulen, Partha Nandy, Italo Poggesi
Pages: 1149 - 1160 - A model based analysis of IPEC dosing of paclitaxel in rats(2014)
Authors: Pieter Colin, Lieselotte De Smet, Chris Vervaet, Wim Ceelen, Koen Boussery, An Vermeulen
Pages: 2876 - 2886 - Mechanistic understanding of brain drug disposition to optimize the selection of potential neurotherapeutics in drug discovery(2014)
Authors: Irena Loryan, Vikash Sinha, Claire Mackie, Achiel Van Peer, Wilhelmus Drinkenburg, An Vermeulen, Denise Morrison, Mario Monshouwer, Donald Heald, Margareta Hammarlund-Udenaes
Pages: 2203 - 2219 - Dopamine D2 receptor occupancy as a predictor of catalepsy in rats: a pharmacokinetic-pharmacodynamic modeling approach(2014)
Authors: Martin Johnson, Magdalena Kozielska, Venkatesh Pilla Reddy, An Vermeulen, Hugh A Barton, Sarah Grimwood, Rik de Greef, Geny MM Groothuis, Meindert Danhof, Johannes H Proost
Pages: 2605 - 2617 - Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries(2013)
Authors: Xu Steven Xu, Mahesh N Samtani, Adrian Dunne, Partha Nandy, An Vermeulen, Filip De Ridder
Pages: 537 - 544 - Modelling and simulation of placebo effect: application to drug development in schizophrenia(2013)
Authors: Venkatesh Pilla Reddy, Magdalena Kozielska, Rik de Greef, An Vermeulen, Johannes H Proost
Pages: 377 - 388 - Population pharmacokinetic-pharmacodynamic modeling of haloperidol in patients with schizophrenia using positive and negative syndrome rating scale(2013)
Authors: Venkatesh Pilla Reddy, Magdalena Kozielska, Martin Johnson, Nyashadzaishe Mafirakureva, An Vermeulen, Jing Liu, Rik de Greef, Dan Rujescu, Geny MM Groothuis, Meindert Danhof, et al.
Pages: 731 - 739 - Modeling continuous bounded outcome scores using beta regression with NONMEM (R) VII(2013)Volume: 40
Authors: Mahesh N Samtani, Xu Steven Xu, Adrian Dunne, Partha Nandy, An Vermeulen, Filip De Ridder
Pages: S66 - S67 - Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D-2-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D-2-receptor occupancy(2013)
Authors: Eef Hoeben, Martine Neyens, Erik Mannaert, Mark Schmidt, An Vermeulen
Pages: 1005 - 1015 - Sensitivity of individual items of the Positive and Negative Syndrome Scale (PANSS) and items subgroups to differentiate between placebo and drug treatment in schizophrenia(2013)
Authors: Magdalena Kozielska, Venkatesh Pilla Reddy, Martin Johnson, Filip de Ridder, An Vermeulen, Jing Liu, Geny MM Groothuis, Meindert Danhof, Johannes H Proost
Pages: 53 - 58